The Public Private Partnership Addressing Literacy-Numeracy to Improve Diabetes Care (PRIDE)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Russell Rothman, Vanderbilt University
ClinicalTrials.gov Identifier:
NCT01344668
First received: April 27, 2011
Last updated: June 20, 2013
Last verified: June 2013

April 27, 2011
June 20, 2013
May 2011
May 2014   (final data collection date for primary outcome measure)
Improvement in A1C at 12 months [ Time Frame: 12 months ] [ Designated as safety issue: No ]
The primary outcome will be the improvement in A1C at 12 months between Intervention group patients and Control group patients.
Same as current
Complete list of historical versions of study NCT01344668 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
The Public Private Partnership Addressing Literacy-Numeracy to Improve Diabetes Care
The Public Private Partnership Addressing Literacy-Numeracy to Improve Diabetes Care

The primary hypotheses are that the intervention will improve A1C, blood pressure, lipids, weight, self-efficacy, self-management behaviors, and use of clinical services at 12 and 24 months follow-up.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Health Services Research
Type 2 Diabetes
  • Other: Enhanced Diabetes Education
    Provide enhanced diabetes education
  • Other: Standard Diabetes Education
    Provide Standard Diabetes Education
  • Standard Diabetes Education
    Standard Diabetes Education
    Intervention: Other: Standard Diabetes Education
  • Enhanced Diabetes Education
    Enhanced Diabetes Education
    Intervention: Other: Enhanced Diabetes Education
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
411
May 2015
May 2014   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patient has a clinical diagnosis of Type 2 Diabetes
  • Age 18-85 years
  • English or Spanish speaking
  • Most recent A1C ≥ 7.5%
  • Patient agrees to participate in the study for the full two years duration.

Exclusion Criteria:

  • Poor visual acuity (vision worse than 20/50 using Rosenbaum Pocket Screener) -- Significant dementia or psychosis (by health provider report or chart review)
  • Terminal illness with anticipated life expectancy < 2 years (per health provider or patient report).
Both
18 Years to 85 Years
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT01344668
101523, 1R18DK083264-01A2
Yes
Russell Rothman, Vanderbilt University
Vanderbilt University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Principal Investigator: Russell L. Rothman, MD, MPP Vanderbilt University
Vanderbilt University
June 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP